Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.

Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, Bohm MK, Jones CM, Flanagan BE, Siddiqi AE, Iqbal K, Dent AL, Mermin JH, McCray E, Ward JW, Brooks JT.

J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):323-331.

PMID:
27763996
2.

Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs.

Ward JW, Mermin JH.

N Engl J Med. 2015 Dec 31;373(27):2678-80. doi: 10.1056/NEJMe1513245. No abstract available.

3.

Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States.

Hutchinson AB, Farnham PG, Sansom SL, Yaylali E, Mermin JH.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):323-30. doi: 10.1097/QAI.0000000000000838.

4.

Human immunodeficiency virus transmission at each step of the care continuum in the United States.

Skarbinski J, Rosenberg E, Paz-Bailey G, Hall HI, Rose CE, Viall AH, Fagan JL, Lansky A, Mermin JH.

JAMA Intern Med. 2015 Apr;175(4):588-96. doi: 10.1001/jamainternmed.2014.8180.

PMID:
25706928
5.

Prevalence and public health implications of state laws that criminalize potential HIV exposure in the United States.

Lehman JS, Carr MH, Nichol AJ, Ruisanchez A, Knight DW, Langford AE, Gray SC, Mermin JH.

AIDS Behav. 2014 Jun;18(6):997-1006. doi: 10.1007/s10461-014-0724-0.

6.

The impact of post-election violence on HIV and other clinical services and on mental health-Kenya, 2008.

Bamrah S, Mbithi A, Mermin JH, Boo T, Bunnell RE, Sharif S, Cookson ST.

Prehosp Disaster Med. 2013 Feb;28(1):43-51. doi: 10.1017/S1049023X12001665.

PMID:
23177022
7.

A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States.

Sorensen SW, Sansom SL, Brooks JT, Marks G, Begier EM, Buchacz K, Dinenno EA, Mermin JH, Kilmarx PH.

PLoS One. 2012;7(2):e29098. doi: 10.1371/journal.pone.0029098.

8.

Cost of community integrated prevention campaign for malaria, HIV, and diarrhea in rural Kenya.

Kahn JG, Harris B, Mermin JH, Clasen T, Lugada E, Grabowksy M, Vestergaard Frandsen M, Garg N.

BMC Health Serv Res. 2011 Dec 21;11:346. doi: 10.1186/1472-6963-11-346.

9.

Return on public health investment: CDC's Expanded HIV Testing Initiative.

Hutchinson AB, Farnham PG, Duffy N, Wolitski RJ, Sansom SL, Dooley SW, Cleveland JC, Mermin JH.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):281-6. doi: 10.1097/QAI.0b013e31823e5bee.

PMID:
22067662
10.

HIV Infection - United States, 2005 and 2008.

Hall HI, Hughes D, Dean HD, Mermin JH, Fenton KA; Centers for Disease Control and Prevention (CDC)..

MMWR Suppl. 2011 Jan 14;60(1):87-9. No abstract available.

PMID:
21430630
11.

Estimated future HIV prevalence, incidence, and potential infections averted in the United States: a multiple scenario analysis.

Hall HI, Green TA, Wolitski RJ, Holtgrave DR, Rhodes P, Lehman JS, Durden T, Fenton KA, Mermin JH.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):271-6. doi: 10.1097/QAI.0b013e3181e8f90c.

PMID:
20634702
12.

Developing WHO guidelines with pragmatic, structured, evidence-based processes: A case study.

Chang LW, Kennedy CE, Kennedy GE, Lindegren ML, Marston BJ, Kaplan JE, Sweat MD, Bunnell RE, O'Reilly K, Rutherford GW, Mermin JH.

Glob Public Health. 2010;5(4):395-412. doi: 10.1080/17441690903473253.

PMID:
20155547
13.

Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt".

Dollard SC, Butler LM, Jones AM, Mermin JH, Chidzonga M, Chipato T, Shiboski CH, Brander C, Mosam A, Kiepiela P, Hladik W, Martin JN.

Int J Cancer. 2010 Nov 15;127(10):2395-401. doi: 10.1002/ijc.25235.

14.

HIV prevalence in voluntary counseling and testing centers compared with national HIV serosurvey data in Uganda.

Baryarama F, Bunnell RE, Montana L, Hladik W, Opio A, Musinguzi J, Kirungi W, Waswa-Bright L, Mermin JH.

J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):183-9. doi: 10.1097/QAI.0b013e31818455b8.

PMID:
18769350
15.

Estimating HIV incidence in voluntary counseling and testing clients in Uganda (1992-2003).

Baryarama F, Bunnell R, McFarland W, Hudes ES, Neilands TB, Ransom RL, Mubangizi J, Hitimana-Lukanika C, Mermin JH.

J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):99-105.

PMID:
17075393
16.

Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda.

Were WA, Mermin JH, Wamai N, Awor AC, Bechange S, Moss S, Solberg P, Downing RG, Coutinho A, Bunnell RE.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):91-5.

PMID:
16885775
17.

Living with discordance: knowledge, challenges, and prevention strategies of HIV-discordant couples in Uganda.

Bunnell RE, Nassozi J, Marum E, Mubangizi J, Malamba S, Dillon B, Kalule J, Bahizi J, Musoke N, Mermin JH.

AIDS Care. 2005 Nov;17(8):999-1012.

PMID:
16176896
18.

Couples at risk: HIV-1 concordance and discordance among sexual partners receiving voluntary counseling and testing in Uganda.

Malamba SS, Mermin JH, Bunnell R, Mubangizi J, Kalule J, Marum E, Hu DJ, Wangalwa S, Smith D, Downing R.

J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):576-80.

PMID:
16044010
19.

Using HIV voluntary counseling and testing data for monitoring the Uganda HIV epidemic, 1992-2000.

Baryarama F, Bunnell RE, Ransom RL, Ekwaru JP, Kalule J, Tumuhairwe EB, Mermin JH.

J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1180-6.

PMID:
15319679
20.

Public health in crisis: outbreaks of Escherichia coli O157:H7 infections in Japan.

Mermin JH, Griffin PM.

Am J Epidemiol. 1999 Oct 15;150(8):797-803; discussion 804-5. No abstract available.

Items per page

Supplemental Content

Loading ...
Support Center